Literature DB >> 1389495

Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis: long-term increase of activated (HLA-DR+) T cells and decrease of "naive" (CD4-CD45R) T lymphocytes.

D De Ruysscher1, M Waer, M Vandeputte, R Aerts, K Vantongelen, E van der Schueren.   

Abstract

Blood lymphocyte subsets of early breast cancer patients and of men with stage I seminoma of the testis were studied up to 6 years after radiotherapy. Similar results were obtained in the two patient groups. After a temporary decrease, the CD4-w29 or "memory" T cells recovered completely, while the CD4-45R or "naive" T cells remained decreased up to 6 years after irradiation. The number of CD8 T lymphocytes did not change during or after treatment. Because of the decrease of a subset of CD4 cells, and the unchanged values of CD8 cells, the CD4/CD8 ratio decreased significantly after irradiation, and remained lower than before treatment up to 5-6 years after radiotherapy. The number of both HLA-DR positive CD4 and HLA-DR positive CD8 T cells ("activated" T cells) increased significantly after irradiation. The natural killer (NK) cells were not affected by treatment. We propose that the recovery of the CD4 cells is limited to the CD4-w29 ("memory") population because of thymic dysfunction in older humans. The impact of the observed immune modulation on the low susceptibility for infections after local irradiation, and on putative antitumour immune responses is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389495     DOI: 10.1016/0959-8049(92)90079-h

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  13 in total

1.  Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse.

Authors:  Maciej Kmieciak; Debasmita Basu; Kyle K Payne; Amir Toor; Adly Yacoub; Xiang-Yang Wang; Lisa Smith; Harry D Bear; Masoud H Manjili
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

2.  Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT.

Authors:  Max O Meneveau; Gina R Petroni; Nikole E Varhegyi; John C Hulse; Anneke T Schroen; David R Brenin; Einsley M Janowski; Adam C Berger; Melissa A Lazar; Nicole L Simone; Timothy N Showalter; Shayna L Showalter
Journal:  Brachytherapy       Date:  2020-06-20       Impact factor: 2.362

Review 3.  Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary?

Authors:  Nadine Housri; Robert Yarchoan; Aradhana Kaushal
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

4.  Down regulation of CD45 expression on CD4 T cells during acute renal allograft rejection: evidence of a decline in T suppressor/inducer activity.

Authors:  M Shabtai; W C Waltzer; A Ayalon; E L Shabtai; K Malinowski
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

5.  Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era.

Authors:  Keri L Calkins; Geetanjali Chander; Corinne E Joshu; Kala Visvanathan; Anthony T Fojo; Catherine R Lesko; Richard D Moore; Bryan Lau
Journal:  JAMA Oncol       Date:  2020-02-01       Impact factor: 31.777

6.  Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors.

Authors:  Stuart A Grossman; Susannah Ellsworth; Jian Campian; Aaron T Wild; Joseph M Herman; Dan Laheru; Malcolm Brock; Ani Balmanoukian; Xiaobu Ye
Journal:  J Natl Compr Canc Netw       Date:  2015-10       Impact factor: 11.908

7.  Peripheral blood complete remission after splenic irradiation in mantle-cell lymphoma with 11q22-23 deletion and ATM inactivation.

Authors:  Andrea Riccardo Filippi; Pierfrancesco Franco; Marco Galliano; Umberto Ricardi
Journal:  Radiat Oncol       Date:  2006-09-06       Impact factor: 3.481

8.  Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide.

Authors:  Susannah Ellsworth; Ani Balmanoukian; Ferdynand Kos; Christopher J Nirschl; Thomas R Nirschl; Stuart A Grossman; Leo Luznik; Charles G Drake
Journal:  Oncoimmunology       Date:  2014-01-03       Impact factor: 8.110

9.  Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC.

Authors:  Kevin Lee Min Chua; Eugenia Li Ling Yeo; Waseem Ahamed Shihabudeen; Sze Huey Tan; Than Than Shwe; Enya Hui Wen Ong; Paula Yeng Po Lam; Khee Chee Soo; Yoke Lim Soong; Kam Weng Fong; Terence Wee Kiat Tan; Joseph Tien Seng Wee; Melvin Lee Kiang Chua
Journal:  BMC Cancer       Date:  2018-11-12       Impact factor: 4.430

10.  Changes of peripheral blood lymphocyte subtypes in patients with end stage cancer administered localized radiotherapy and bojungikki-tang.

Authors:  A-Jin Lee; Ho Jun Lee; Jong-Dae Kim; Hyun-Jung Jung; Sung Hwa Bae; Hun Mo Ryoo; Sang-Gyung Kim
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.